Investigation of the Efficacy and Safety of JTT-751in Hemodialysis Patients
Phase 2
- Conditions
- Chronic renal failure
- Registration Number
- JPRN-jRCT2080220681
- Lead Sponsor
- JAPAN TABACCO INC.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 168
Inclusion Criteria
Patients with chronic renal failure undergoing hemodialysis 3 times a week
Exclusion Criteria
Patients with gastrointestinal diseases, such as peptic ulcer etc.
Patients with advanced cardiac disease or hepatic dysfunction etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy, Safety
- Secondary Outcome Measures
Name Time Method